Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-21
2008-12-30
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S469000
Reexamination Certificate
active
07470799
ABSTRACT:
Compounds of formula I are provided:wherein each of R1, R2, y, m, n, and Ar are as defined, and described in classes and subclasses herein, which are agonists or partial agonists of melatoninergic receptors. The compounds, and compositions containing the compounds, can be used to treat melatoninergic disorders.
REFERENCES:
patent: 5308866 (1994-05-01), Lesieur et al.
patent: 5541228 (1996-07-01), Takaki et al.
patent: 6211225 (2001-04-01), Takaki et al.
patent: 6214869 (2001-04-01), Chen et al.
patent: 6569894 (2003-05-01), Takaki et al.
patent: 2003/0216456 (2003-11-01), Takaki et al.
patent: 2005/0124692 (2005-06-01), Gross et al.
patent: 2005/0143452 (2005-06-01), Gross et al.
patent: 2005/0261347 (2005-11-01), Gross et al.
patent: 2006/0089405 (2006-04-01), Zhou
patent: 2006/0111438 (2006-05-01), Gontcharov et al.
patent: 2006/0241172 (2006-10-01), Zhou et al.
patent: 2006/0241176 (2006-10-01), Stack et al.
patent: 2006/0246551 (2006-11-01), Stack et al.
patent: 2006/0247276 (2006-11-01), Gross et al.
patent: 2006/0252825 (2006-11-01), Tadayon et al.
patent: 2006/0258639 (2006-11-01), Logue et al.
patent: 2006/0258711 (2006-11-01), Rosenzweig-Lipson
patent: 2006/0258712 (2006-11-01), Jacobson
patent: 2006/0258713 (2006-11-01), Rosenzweig-Lipson
patent: 2006/0258714 (2006-11-01), Heffernan et al.
patent: 2006/0258715 (2006-11-01), Jandura et al.
patent: 2006/0258739 (2006-11-01), Ai et al.
patent: 0718286 (A) (1996-06-01), None
patent: WO 97/06140 (A) (1997-02-01), None
patent: WO 2006/000902 (2006-05-01), None
U.S. Appl. No. 11/787,929, Yu et al.
U.S. Appl. No. 11/787,860, Gontcharov et al.
U.S. Appl. No. 11/726,941, Rosenzweig-Lipson.
U.S. Appl. No. 11/787,663, Mirmehrabi.
Papp, M., et al., Neuropsychopharmacology, 28(4), 694 (2003).
Bourin, M., et al., Journal of Psychiatry and Neuroscience, 29(2), 126 (2004).
Loo, H., et al., L'Encephale, 29(2), 165 (2003).
Bundgaard, et al., Journal of Drug Delivery Reviews, 8: 1-38 (1992).
Millan, M. J., et al., Neuropharmacology 37: 953-955, 1998.
Di Matteo, V., et al., Neuropharmacology, 38: 1195-1205, 1999.
Di Giovanni, G., et al., Synapse, 35: 53-61, 2000.
Bundgaard, J. of Pharmaceutical Sciences, 77: 285 et seq. (1988).
Cowen, P. J., et al., Human Psychopharmacology 10: 385-391, 1995.
Rosenzweig-Lipson, S., et al., ASPET abstract, 2000.
Wilen, S. H., et al., Tetrahedron, 33: 2725 (1977).
Audinot, V., et al., “New selective ligands of human cloned melatonin MT1 and MT2 receptors,” Nauyn-Schmiedeberg's Arch Pharmacol, 2003, 367: 553-561.
International Search Report for PCT/US2006/015172, mailed Oct. 5, 2006.
Written Opinion of International Searching Authority, PCT/US2006/015172, mailed Oct. 5, 2006.
Gross Jonathan Laird
Stack Gary Paul
Chandrakumar Nizal S
Choate Hall & Stewart LLP
Knight Julie Anne
Robidoux Andrea L.
Seaman D. Margaret
LandOfFree
Dihydrobenzofuran derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydrobenzofuran derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydrobenzofuran derivatives and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4050790